Temozolomide plus thalidomide in patients with brain metastases from melanoma: A phase II study Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Brain Neoplasms
  • Dacarbazine
  • Melanoma
  • Skin Neoplasms

abstract

  • Temozolomide plus thalidomide was an active oral regimen for patients with brain metastases from malignant melanoma.

publication date

  • June 15, 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.21081

PubMed ID

  • 15861414

Additional Document Info

start page

  • 2590

end page

  • 7

volume

  • 103

number

  • 12